North Texas is seeing a troubling rise in flu cases as health officials track a new mutation of the H3N2 virus that’s quickly becoming the dominant strain across the country.
The variant, officially dubbed “subclade K,” now accounts for a staggering 89% of flu viruses tested by the CDC in recent weeks, according to local health officials. Despite its rapid spread, doctors say the symptoms remain consistent with typical flu presentations.
“So the same things that you see with a regular flu, such as high fever, muscle aches, pneumonias, asthma attacks, things like that, are not different to what we normally see with the flu. And so the clinical presentation at this point looks the same,” Termulo said.
Tracking the Spread
The CDC’s latest surveillance data paints a concerning picture. Among 55 influenza A(H3N2) viruses collected since late September that underwent additional genetic characterization, 82% belonged to subclade K. Though hospitalization rates remain relatively low at 7.9 per 100,000 people, that number is steadily ticking upward, shows the most recent CDC data.
What exactly is this new variant? Originally classified as subclade J.2.4.1, the mutation was identified in August 2025 and subsequently renamed “H3N2 subclade K.” The good news? Current flu vaccines appear to remain effective against it, indicates recent research.
Still, health officials aren’t taking chances. The emergence of subclade K comes at a particularly challenging time for America’s healthcare system, which is already grappling with reduced community vaccination rates and a multi-state measles outbreak.
Perfect Storm?
Is this the beginning of a more severe flu season? That’s what has many healthcare providers concerned. Hospitals across the country are enhancing their preparedness measures in response to these converging health threats, reveals a healthcare industry analysis.
The timing couldn’t be worse. Winter typically brings increased respiratory illness circulation, and with holiday travel and gatherings on the horizon, the potential for accelerated transmission remains high.
“We’re watching the situation carefully,” one North Texas health official noted, speaking on condition of anonymity because they weren’t authorized to talk publicly. “But the best protection is still the same – get your flu shot, wash your hands frequently, and stay home if you’re sick.”
For now, public health messaging remains focused on vaccination as the primary defense against this evolving threat – a familiar refrain in an increasingly complex viral landscape.
